sIL27RA translocates from the cytoplasm to the extracellular region

Stable Identifier
R-HSA-8950271
Type
Reaction [uncertain]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Inferred from mouse:
Mouse Soluble isoform of Interleukin-27 receptor alpha subunit (sIl27ra or WSX-1) can be produced by two mechanisms. There is experimental evidence of expression of sIl27ra in primary cortical neurons (PCNs) (Hashimoto et al. 2010). Human sIL27RA is produced by activated CD4(+) and CD8(+) T cells, B cells, myeloid cells and various cell lines.

sIL27RA is released as two N-glycosylated variants of around 90 and 70 kDa. Production is inhibited by the metalloprotease inhibitors GM6001 (galardin, ilomastat) and Tumor necrosis factor-alpha processing inhibitor-0 (TAPI-0). sIL27RA is a natural antagonist of Interleukin-27 (Dietrich et al. 2014)
As the origin of sIL27RA is unclear this is a black box event.

Participants
Participant Of
Inferred From
Authored
Reviewed
Created
Cite Us!